Corzide 40/5 Interactions
There are 618 drugs known to interact with Corzide 40/5 (bendroflumethiazide/nadolol), along with 30 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 52 are major, 524 are moderate, and 42 are minor.
- View all 618 medications that may interact with Corzide 40/5
- View Corzide 40/5 alcohol/food interactions (5)
- View Corzide 40/5 disease interactions (30)
Most frequently checked interactions
View interaction reports for Corzide 40 / 5 (bendroflumethiazide / nadolol) and the medicines listed below.
- Actos (pioglitazone)
- Advair Diskus (fluticasone / salmeterol)
- Benicar (olmesartan)
- BuSpar (buspirone)
- doxepin
- famotidine
- fenofibrate
- Flexeril (cyclobenzaprine)
- gabapentin
- Norvasc (amlodipine)
- Prozac (fluoxetine)
- Restoril (temazepam)
- Singulair (montelukast)
- Vistaril (hydroxyzine)
- Xarelto (rivaroxaban)
- Zyrtec (cetirizine)
Corzide 40/5 alcohol/food interactions
There are 5 alcohol/food interactions with Corzide 40 / 5 (bendroflumethiazide / nadolol).
Corzide 40/5 disease interactions
There are 30 disease interactions with Corzide 40 / 5 (bendroflumethiazide / nadolol) which include:
- bradyarrhythmia/AV block
- cardiogenic shock/hypotension
- CHF
- diabetes
- hemodialysis
- hypersensitivity
- ischemic heart disease
- PVD
- renal dysfunction
- asthma/COPD
- anuria
- electrolyte losses
- liver disease
- lupus erythematosus
- renal function disorders
- cerebrovascular insufficiency
- glaucoma
- hyperlipidemia
- hyperthyroidism
- myasthenia gravis
- pheochromocytoma
- psoriasis
- tachycardia
- Prinzmetal's variant angina
- asthma
- diabetes
- hyperlipidemia
- hyperparathyroidism
- hyperuricemia
- thyroid function tests
More about Corzide 40 / 5 (bendroflumethiazide / nadolol)
- Corzide 40/5 consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: beta blockers with thiazides
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.